Royal Bank Of Canada Bio Cardia, Inc. Transaction History

Royal Bank Of Canada

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 Nov 05, 2024	BUY	$0.38 - $0.68 $42 - $76	113 New	113 $0
Q1 2024 May 15, 2024	SELL	$0.38 - $0.68 $41 - $74	-110 Reduced 49.33%	113 $0
Q4 2023 Feb 14, 2024	BUY	$0.37 - $1.07 $82 - $238	223 New	223 $0

Ticker BCDA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 17,758,200
Market Cap $39.8M
Description
BioCardia, Inc., a clinical-stage regenerative medicine company, develops cellular and cell-derived therapeutics for cardiovascular and pulmonary diseases. Its lead therapeutic candidate is the CardiAMP Cell Therapy System for the treatment of heart failure and chronic myocardial ischemia; and allogeneic cell therapy for cardiac and pulmonary di...

Get notified when there are updates to the investment portfolio of Royal Bank Of Canada, based on Form 13F filings with the SEC.

Stay updated on Royal Bank Of Canada with notifications on news.